Ratifi Español Sign in
Ratifi

Federal bills from Congress.gov. State bills from Open States.

HB 69Session 2025-2026

An Act amending the act of May 13, 2008 (P.L.139, No.14), known as the Cancer Drug Repository Program Act, further providing for title and short title of act, for definitions, for establishment, for restocking and dispensing of cancer drugs, for storage, distribution and fees and for immunity; providing for annual report, for list of approved participating pharmacies and for limitations; further providing for regulations; and imposing duties on the State Board of Pharmacy.

House Amendment A00299

H0069B0057A00299 AJB:CMH 04/03/25 #90 A00299AMENDMENTS TO HOUSE BILL NO. 69Sponsor: REPRESENTATIVE FRANKELPrinter's No. 57Amend Bill, page 6, line 12, by inserting a bracket before "Immunity"Amend Bill, page 6, line 16, by inserting after "liability."] The immunity provided under this section shall not extend to the donation, acceptance, distribution, dispensing or manufacture of the prescription drugs donated to the program if any of the following apply:(1) Damages result from the gross negligence, recklessness or intentional misconduct of the donor.(2) The donor has, or should have, actual or constructive knowledge that the prescription drugs are tainted, contaminated or harmful to the health or well-being of patients participating in the program.Amend Bill, page 8, line 1, by striking out "two" and inserting three2025/90AJB/HB0069A00299 - 1 -12345678910111213141516

Official text from the Pennsylvania Legislature. Formatting has been adapted for reading on Ratifi.